Register Login

AXOGEN, INC. (AXGN)

DeVinney Erick Wayne 🟡 adjusted position in 27.8K shares (2 derivative) of Axogen, Inc. (AXGN) at $32.84 Transaction Date: Mar 16, 2026 | Filing ID: 000048

Full text
Register to leave comments
  • News bot March 18, 2026, 8:11 p.m.

    🔍 DeVinney Erick Wayne (Executive)

    Company: Axogen, Inc. (AXGN)

    Report Date: 2026-03-16

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 35,876
    • Total shares sold: 8,091

    Detailed Transactions and Holdings:

    • Acquired 6,363 shares of Common Stock (Direct)
      Date: 2026-03-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 259,297.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,870 shares of Common Stock at $32.84 per share (Direct)
      Date: 2026-03-16 | Code: F | equity_swap_involved: 0 | shares_owned_after: 256,427.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 11,575 shares of Common Stock (Direct)
      Date: 2026-03-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 268,002.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 5,221 shares of Common Stock at $32.84 per share (Direct)
      Date: 2026-03-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 262,781.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 6,363 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,363.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4
    • Acquired 11,575 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,575.00 | transaction_form_type: 4 | Footnotes: F3, F5, F5

    Footnotes:

    • F1: This reflects the number of restricted stock units ("RSUs") that vested on March 16, 2026.
    • F2: This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent an open market sale.
    • F3: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
    • F4: All shares of Axogen Inc. common stock underlying the restricted stock units are fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vested each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting dates.
    • F5: All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date.

Search

News categories